Австралия - английский - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - d-alpha-tocopherol,fish oil - natural,rosemary oil -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - d-alpha-tocopherol,fish oil - natural,rosemary oil -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - borago officinalis,d-alpha-tocopherol,fish oil - natural,rosemary oil -

Австралия - английский - Department of Health (Therapeutic Goods Administration)

nordic naturals australasia pty ltd - d-alpha-tocopherol,fish oil - natural,rosemary oil -

Европейский союз - английский - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - stomach neoplasms - antineoplastic agents - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5.1).- as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Европейский союз - английский - EMA (European Medicines Agency)

bavarian nordic a/s - modified vaccinia ankara - bavarian nordic (mva-bn) virus - smallpox vaccine; monkeypox virus - other viral vaccines, - active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in adults (see sections 4.4 and 5.1).the use of this vaccine should be in accordance with official recommendations.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

hydrosilex australia pty ltd - 9951 - disinfectant, household/commercial grade - other therapeutic

Соединенные Штаты - английский - NLM (National Library of Medicine)

bavarian nordic a/s - vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen (unii: tu8j357395) (vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen - unii:tu8j357395) - jynneos is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. available human data on jynneos administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. the effect of jynneos on embryo-fetal and post-natal development was evaluated in four developmental toxicity studies conducted in female rats and rabbits. in two studies, rats were administered a single human dose of jynneos (0.5 ml) once prior to mating and on one or two occasions during gestation. in the third study, rats were administered a single human dose of jynneos (0.5 ml) on two occasions during gestation. in the fourth study, rabbits were ad

Канада - английский - Health Canada

bavarian nordic as - modified vaccinia virus (ankara-bavarian nordic) - suspension - 50000000ccid50 - modified vaccinia virus (ankara-bavarian nordic) 50000000ccid50 - vaccines

Соединенные Штаты - английский - NLM (National Library of Medicine)

the nordic shield aps - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available.